Abstract 5779: RCZY-869: A highly potent, selective, and orally bioavailable covalent KRASG12D (ON-state) inhibitor with robust antitumor activity in preclinical models of KRASG12D-driven solid tumors
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Xiaojing (Celia) Chen, Lin Wang, Xiaohong Liu, Dan Wang, Jianming Bao
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148655015
Cites:
Cited by:
Related to: